We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODI icon
1676
Compass Diversified
CODI
$908M
$1.36M ﹤0.01%
80,000
-155,380
-66% -$2.67M
EGBN icon
1677
Eagle Bancorp
EGBN
$877M
$1.35M ﹤0.01%
23,316
+5,390
+30% +$345K
TKR icon
1678
Timken Company
TKR
$9.03B
$1.35M ﹤0.01%
27,459
+5,800
+27% +$281K
BYD icon
1679
Boyd Gaming
BYD
$6.03B
$1.33M ﹤0.01%
38,013
-20
-0.1% -$605
QTS
1680
DELISTED
QTS REALTY TRUST, INC.
QTS
$1.33M ﹤0.01%
24,523
-10
-0% -$557
KFRC icon
1681
Kforce
KFRC
$1.03B
$1.32M ﹤0.01%
52,164
-10
-0% -$235
PBF icon
1682
PBF Energy
PBF
$8.81B
$1.32M ﹤0.01%
37,155
-1,094,905
-97% -$33.8M
CNX icon
1683
CNX Resources
CNX
$5.29B
$1.31M ﹤0.01%
89,685
+13,671
+18% +$189K
BRX icon
1684
Brixmor Property Group
BRX
$9.12B
$1.31M ﹤0.01%
70,231
-5,990
-8% -$110K
MCHB
1685
Mechanics Bancorp
MCHB
$3.8B
$1.31M ﹤0.01%
45,161
-20
-0% -$580
BLCM
1686
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.31M ﹤0.01%
15,543
+3
+0% +$294
BCPC
1687
Balchem Corp
BCPC
$5.65B
$1.31M ﹤0.01%
16,209
-10
-0.1% -$833
MNR
1688
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.3M ﹤0.01%
73,203
+2,170
+3% +$37.5K
NVRI icon
1689
Enviri
NVRI
$583M
$1.3M ﹤0.01%
69,771
+24,882
+55% +$479K
VSAT icon
1690
Viasat
VSAT
$11.4B
$1.3M ﹤0.01%
17,379
-4,970
-22% -$344K
SPN
1691
DELISTED
Superior Energy Services, Inc.
SPN
$1.3M ﹤0.01%
13,490
+876
+7% +$81.3K
DOC
1692
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.3M ﹤0.01%
72,172
+9,674
+15% +$173K
HWC icon
1693
Hancock Whitney
HWC
$6.34B
$1.3M ﹤0.01%
26,177
+1,280
+5% +$63.3K
MPT
1694
Medical Properties Trust
MPT
$2.42B
$1.3M ﹤0.01%
94,043
+300
+0.3% +$4.05K
SXT icon
1695
Sensient Technologies
SXT
$5.53B
$1.29M ﹤0.01%
17,644
-1,662
-9% -$127K
BGG
1696
DELISTED
Briggs & Stratton Corp.
BGG
$1.27M ﹤0.01%
50,207
-4,310
-8% -$106K
CATY icon
1697
Cathay General Bancorp
CATY
$4.31B
$1.27M ﹤0.01%
30,156
-10
-0% -$418
NBR icon
1698
Nabors Industries
NBR
$1.33B
$1.27M ﹤0.01%
3,717
-572
-13% -$182K
SAVE
1699
DELISTED
Spirit Airlines, Inc.
SAVE
$1.27M ﹤0.01%
28,296
-340,661
-92% -$13.1M
LNW
1700
DELISTED
Light & Wonder
LNW
$1.27M ﹤0.01%
24,712
-3,880
-14% -$189K

Similar funds

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.